Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dysport in Pediatric Upper Limb Spasticity
NCT02106351Phase 3Completed
- Sponsor
- Ipsen
- Start
- Apr 2014
- Primary completion
- Sep 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 8
01
Overview
A Phase 3 trial of abobotulinumtoxinA in Upper limb spasticity, sponsored by Ipsen. Started Apr 2014; status: completed.
02
Drugs
abobotulinumtoxinA
03
Conditions
Upper limb spasticity
Beyond the preview
Go deeper on NCT02106351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02106351.